Skip to main content

Table 5 In-hospital management of ChoCO patients: comparison between COVID and non-COVID patients

From: The ChoCO-W prospective observational global study: Does COVID-19 increase gangrenous cholecystitis?

Management

Non-COVID group n = 2412

COVID group n = 180

p

Primary radiological diagnosis

  

0.19

 Ultrasound

1604 (66.9%)

110 (61.8%)

 

 CT scan

795 (33.1%)

68 (38.2%)

 

Delay in intervention (h)

45.9 (110.1)

63.44 (201.4)

0.89

Surgery

  

p < 0.0001

 Laparoscopic total cholecystectomy

1401 (76.6%)

75 (58.1%)

 

 Laparoscopic total cholecystectomy and intraoperative cholangiography

135 (7.4%)

10 (7.8%)

 

 Laparoscopic partial cholecystectomy

21 (1.1%)

1 (0.8%)

 

 Open total cholecystectomy

123 (6.7%)

29 (22.5%)

 

 Open total cholecystectomy and intraoperative cholangiography

17 (0.9%)

2 (1.6%)

 

 Open partial cholecystectomy after conversion

18 (1%)

1 (0.8%)

 

 Open partial cholecystectomy

17 (0.9%)

2 (1.6%)

 

 Open total cholecystectomy after conversion

98 (5.4%)

9 (0.7%)

 

Adequate source control

2206 (94.6%)

158 (93.5%)

0.48

Adequate empirical antibiotics

2317 (97.9%)

169 (95.5%)

0.48

Reoperation

55 (2.6%)

10 (14.6%)

0.011

Strategy for reoperation

  

0.11

 Laparoscopy

16 (23.9)

2 (15.4)

 

 On demand laparotomy

16 (23.9)

3 (23.1)

 

 Planned laparotomy

7 (10.4)

5 (38.5)

 

 Radiological intervention

28 (41.8)

3 (23.1)

 

Ventilation

67 (2.8%)

30 (16.8%)

p < 0.0001

Ventilation time (days)

5 (6.6)

4.55 (4.1)

0.67

Parenteral nutrition

145 (6.1%)

39 (22.2%)

p < 0.0001

Parenteral nutrition time (days)

4.01 (4.78)

6.95 (6.5)

p = 0.001

  1. CT computer tomography